Operational Update June quarter
Filed with ASX · · 5 pages · English
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- CEO and CSO Appointments
- Operational Update March Quarter
- Response to ASX Price Query
- Genentech extends research collaboration period
- NHMRC Grant Awarded to Collaborators
Later from PYC Therapeutics
- Response to ASX Query
- Appendix 4E - Preliminary Final Report 30 June 2017
- New Delivery Vehicles Show Improved Performance Inside Cells
- PYC Granted US Patent for Peptides Entering Brain Cells
- Quarterly Update and Appendix 4C
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics